Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition.

[1]  D. Aunis,et al.  Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance , 2006, International Journal of Developmental Neuroscience.

[2]  P. Altevogt,et al.  L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. , 2006, Cancer letters.

[3]  N. Matsumura,et al.  Oncogenic Property of Acrogranin in Human Uterine Leiomyosarcoma: Direct Evidence of Genetic Contribution in In vivo Tumorigenesis , 2006, Clinical Cancer Research.

[4]  L. Turnbull,et al.  Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours. , 2005, International journal of oncology.

[5]  M. Monden,et al.  Inhibition of cell movement and proliferation by cell–cell contact-induced interaction of Necl-5 with nectin-3 , 2005, The Journal of cell biology.

[6]  O. Stoeltzing,et al.  Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells , 2005, British Journal of Cancer.

[7]  K. Nakao,et al.  Role of premature leptin surge in obesity resulting from intrauterine undernutrition. , 2005, Cell metabolism.

[8]  Colleen A Crane,et al.  Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  L. Ellis,et al.  Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. , 2004, The American journal of pathology.

[10]  D. Birnbaum,et al.  Comparative multi‐methodological measurement of ERBB2 status in breast cancer , 2004, The Journal of pathology.

[11]  Richard D Schulick,et al.  Expression of Neuropilin-1 in High-grade Dysplasia, Invasive Cancer, and Metastases of the Human Gastrointestinal Tract , 2004, The American journal of surgical pathology.

[12]  J. Verhaagen,et al.  Sema3A regulates the timing of target contact by cranial sensory axons , 2004, The Journal of comparative neurology.

[13]  S. Fujii,et al.  C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro , 2003, British Journal of Cancer.

[14]  D. Mukhopadhyay,et al.  Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration* , 2003, Journal of Biological Chemistry.

[15]  Y. Tabata,et al.  In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[16]  W. Robinson,et al.  Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors. , 2003, Anticancer research.

[17]  B. Eickholt,et al.  Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. , 2003, Cancer research.

[18]  Gong Yang,et al.  Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer , 2003, Oncogene.

[19]  Lee M Ellis,et al.  Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin‐1 by epidermal growth factor in human pancreatic carcinoma , 2003, Cancer.

[20]  S. Ito,et al.  Immunolocalization of nuclear transcription factors, DAX-1 and COUP-TF II, in the normal human ovary: correlation with adrenal 4 binding protein/steroidogenic factor-1 immunolocalization during the menstrual cycle. , 2003, The Journal of clinical endocrinology and metabolism.

[21]  Sushanta K Banerjee,et al.  Neuropilin‐1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer , 2002, International journal of cancer.

[22]  L. Shaw,et al.  Advances in Brief Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells 1 , 2001 .

[23]  S. Soker,et al.  Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  A. Guha,et al.  Expression and regulation of neuropilin‐1 in human astrocytomas , 2000, International journal of cancer.

[25]  O. Cussenot,et al.  VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms , 2000, International journal of cancer.

[26]  I. Konishi,et al.  Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology. , 1998, Human pathology.

[27]  S. Takagi,et al.  Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers. , 1995, Developmental neuroscience.

[28]  A. Herbst.  The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. , 1994, American journal of obstetrics and gynecology.

[29]  R. Scully.  Ovarian tumors. A review. , 1977, The American journal of pathology.